For assessment of molecular fluorescence imaging, preclinical studies used the anti-EGFR antibody cetuximab labeled with fluorescein isothiocyanate (FITC) to image EGFR-expressing MKN45 cancer cells [17]. Here, EGFR is linked to cancer.